Our Transactions

We are relentless in our commitment to achieving extraordinary outcomes that redefine the standard of excellence.

Sectors
Transaction Type

The Board of Directors of

has won re-election in a proxy contest against an alternative slate of directors

Immucor Board of Directors Re-Elected

TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor’s directors were successfully re-elected

Details

$41,925,000 Financial Restructuring

$15,500,000 Revolving Credit Facility $26,425,000 Term Loan

Immucor Completes Debt Restructuring

TM Capital assisted Immucor, Inc. (NASDAQ) in restructuring $42 million of senior indebtedness

Details

$10,000,000

Recapitalization Transaction

Jensen Completes Recapitalization

TM Capital assisted Jensen Industries Inc. in completing a recapitalization transaction

Details

has been acquired by

a subsidiary of

Transart Acquired by Young & Rubicam

TM Capital assisted in the sale of Transart Educational Marketing Services Ltd. to Sudler & Hennessey, a subsidary of Young & Rubicam Inc.

Details

$214,000,000

has been acquired through a cash tender offer by

SteriGenics Acquired by IBA

TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash

Details

has been acquired by Innovex Inc., a subsidiary of

Medcom Acquired by Quintiles

TM Capital completed the sale of Medcom, Inc. to Quintiles Transnational Corp. (NASDAQ)

Details

has acquired

SteriGenics Acquires Irradiation Industries

TM Capital assisted SteriGenics International, Inc. (NASDAQ) in the strategic acquisition of Irradiation Industries, Inc.

Details

has acquired the BCA product line from

Immucor Acquires Division of Biopool

TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)

Details

has acquired through a cash tender offer

Immucor Acquires Gamma Biologicals

TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer

Details

$15,000,000 Senior Debt Financing

International Murex Completes Financing

TM Capital arranged $15 million of senior debt financing for International Murex Technologies Corporation (NASDAQ)

Details

has acquired the

division of ThermoSpectra Corporation an indirect subsidiary of

SteriGenics Acquires Nicolet from Thermo

TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring Nicolet Electron Services from the Thermo-Electron Group (NYSE)

Details

has acquired

SteriGenics Acquires RTI

TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.

Details

a subsidiary of

has been acquired by

Heico Sells Meditek to U.S. Diagnostic Labs

TM Capital advised Heico Corporation (NYSE: HEI) in the sale of its subsidiary Meditek for $23 million to U.S. Diagnostic Labs, Inc. (NASDAQ)

Details

has been acquired by

Medical Diagnostics Acquired by ANMR

TM Capital completed the $29 million sale of Medical Diagnostics, Inc. (NASDAQ) to Advanced NMR Systems Inc. (NASDAQ) following an unsolicited tender offer by Raytel Medical Corp. (NASDAQ)

Details

has been acquired through a stock swap merger by

Armstrong Pharma Acquired by Medeva

TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)

Details
Previous
Load More